CCL5/CCR5 was also demonstrated to be linked with inflammatory bowel disease by Ye et al. [24] and Mencarelli et al. [25] and breast cancer by Velasco-Velázquez et al. [26]. Here, CCR5 is linked to breast carcinoma.